BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...


Balance Therapeutics is a clinical-stage pharmaceutical company developing therapies to improve the lives of patients with debilitating neurological conditions. The company focuses on areas of high unmet medical need where neurobiological pathways provide a strong rationale for our pharmacological approach. Balance's experienced drug development team is committed to advancing products to deliver life-improving medicines that serve patients and their families. The company's principal areas of focus are sleep disorders and cognitive deficits.